Rectum-conserving surgery in the era of chemoradiotherapy

British Journal of Surgery

Volumn 97, Issue 12, 2010, Pages 1752-1764

  Smith, F M ^a   Waldron, D ^a   Winter, D C ^b  

^a UNIVERSITY HOSPITAL LIMERICK   (Ireland)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL SURGERY; ADJUVANT THERAPY; HUMAN; METHODOLOGY; PATHOLOGY; PROGNOSIS; RECTUM; RECTUM TUMOR; REVIEW; SENTINEL LYMPH NODE BIOPSY; STOMA; TREATMENT OUTCOME;

DIGESTIVE SYSTEM SURGICAL PROCEDURES; HUMANS; NEOADJUVANT THERAPY; PROGNOSIS; RECTAL NEOPLASMS; RECTUM; SENTINEL LYMPH NODE BIOPSY; SURGICAL STOMAS; TREATMENT OUTCOME;

EID: 78449292374     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7251     Document Type: Review

References (86)

1. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 1997; 336: 980-987.
2. Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, et al., Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345: 638-646.
3. Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, et al., Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1731-1740.
4. Smith FM, Reynolds JV, Miller N, Stephens RB, Kennedy MJ,. Pathological and molecular predictors of the response of rectal cancer to neoadjuvant radiochemotherapy. Eur J Surg Oncol 2006; 32: 55-64.
5. Beddy D, Hyland JM, Winter DC, Lim C, White A, Moriarty M, et al., A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy. Ann Surg Oncol 2008; 15: 3471-3477.
6. Mignanelli ED, de Campos-Lobato LF, Stocchi L, Lavery IC, Dietz DW,. Downstaging after chemoradiotherapy for locally advanced rectal cancer: is there more (tumor) than meets the eye? Dis Colon Rectum 2010; 53: 251-256.
7. Tsai BM, Finne CO, Nordenstam JF, Christoforidis D, Madoff RD, Mellgren A,. Transanal endoscopic microsurgery resection of rectal tumors: outcomes and recommendations. Dis Colon Rectum 2010; 53: 16-23.
8. Lebedyev A, Tulchinsky H, Rabau M, Klausner JM, Krausz M, Duek SD,. Long-term results of local excision for T1 rectal carcinoma: the experience of two colorectal units. Tech Coloproctol 2009; 13: 231-236.
9. Habr-Gama A, Perez RO, Nadalin W, Sabbaga J, Ribeiro U Jr, Silva e Sousa AH Jr, et al., Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 2004; 240: 711-717.
10. Habr-Gama A, Perez RO,. Non-operative management of rectal cancer after neoadjuvant chemoradiation. Br J Surg 2009; 96: 125-127.
11. Hüser N, Michalski CW, Erkan M, Schuster T, Rosenberg R, Kleeff J, et al., Systematic review and meta-analysis of the role of defunctioning stoma in low rectal cancer surgery. Ann Surg 2008; 248: 52-60.
12. Bujko K, Richter P, Kodziejczyk M, Nowacki MP, Kulig J, Popiela T, et al., Preoperative radiotherapy and local excision of rectal cancer with immediate radical re-operation for poor responders. Radiother Oncol 2009; 92: 195-201.
13. Guerrieri M, Baldarelli M, Organetti L, Grillo Ruggeri F, Mantello G, Bartolacci S, et al., Transanal endoscopic microsurgery for the treatment of selected patients with distal rectal cancer: 15 years experience. Surg Endosc 2008; 22: 2030-2035.
14. Habr-Gama A, Perez RO, Proscurshim I, Nunes Dos Santos RM, Kiss D, Gama-Rodrigues J, et al., Interval between surgery and neoadjuvant chemoradiation therapy for distal rectal cancer: does delayed surgery have an impact on outcome? Int J Radiat Oncol Biol Phys 2008; 71: 1181-1188.
15. Kim CJ, Yeatman TJ, Coppola D, Trotti A, Williams B, Barthel JS, et al., Local excision of T2 and T3 rectal cancers after downstaging chemoradiation. Ann Surg 2001; 234: 352-358.
16. Lezoche E, Guerrieri M, Paganini AM, Baldarelli M, De Sanctis A, Lezoche G,. Long-term results in patients with T2-3 N0 distal rectal cancer undergoing radiotherapy before transanal endoscopic microsurgery. Br J Surg 2005; 92: 1546-1552.
17. Lezoche G, Baldarelli M, Guerrieri M, Paganini AM, De Sanctis A, Bartolacci S, et al., A prospective randomized study with a 5-year minimum follow-up evaluation of transanal endoscopic microsurgery versus laparoscopic total mesorectal excision after neoadjuvant therapy. Surg Endosc 2008; 22: 352-358.
18. Park C, Lee W, Han S, Yun S, Chun HK,. Transanal local excision for preoperative concurrent chemoradiation therapy for distal rectal cancer in selected patients. Surg Today 2007; 37: 1068-1072.
19. Schell SR, Zlotecki RA, Mendenhall WM, Marsh RW, Vauthey JN, Copeland EM III,. Transanal excision of locally advanced rectal cancers downstaged using neoadjuvant chemoradiotherapy. J Am Coll Surg 2002; 194: 584-590.
20. Callender GG, Das P, Rodriguez-Bigas MA, Skibber JM, Crane CH, Krishnan S, et al., Local excision after preoperative chemoradiation results in an equivalent outcome to total mesorectal excision in selected patients with T3 rectal cancer. Ann Surg Oncol 2010; 17: 441-447.
21. Kalady MF, de Campos-Lobato LF, Stocchi L, Geisler DP, Dietz D, Lavery IC, et al., Predictive factors of pathologic complete response after neoadjuvant chemoradiation for rectal cancer. Ann Surg 2009; Epub ahead of print 25 August 2009.
22. Das P, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Wolff RA, et al., Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer. Cancer 2007; 109: 1750-1755.
23. Rebischung C, Gérard JP, Gayet J, Thomas G, Hamelin R, Laurent-Puig P,. Prognostic value of P53 mutations in rectal carcinoma. Int J Cancer 2002; 100: 131-135.
24. Qiu H, Sirivongs P, Rothenberger M, Rothenberger DA, Garciá- Aguilar J,. Molecular prognostic factors in rectal cancer treated by radiation and surgery. Dis Colon Rectum 2000; 43: 451-459.
25. Fu CG, Tominaga O, Nagawa H, Nita ME, Masaki T, Ishimaru G, et al., Role of p53 and p21/WAF1 detection in patient selection for preoperative radiotherapy in rectal cancer patients. Dis Colon Rectum 1998; 41: 68-74.
26. Rödel C, Grabenbauer GG, Papadopoulos T, Bigalke M, Günther K, Schick C, et al., Apoptosis as a cellular predictor for histopathologic response to neoadjuvant radiochemotherapy in patients with rectal cancer. Int J Radiat Oncol Biol Phys 2002; 52: 294-303.
27. Castaldo ET, Parikh AA, Pinson CW, Feurer ID, Merchant NB,. Improvement of survival with response to neoadjuvant radiation therapy for rectal cancer. Arch Surg 2009; 144: 129-134.
28. García-Aguilar J, Hernandez de Anda E, Sirivongs P, Lee SH, Madoff RD, Rothenberger DA,. A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision. Dis Colon Rectum 2003; 46: 298-304.
29. Guillem JG, Chessin DB, Cohen AM, Shia J, Mazumdar M, Enker W, et al., Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer. Ann Surg 2005; 241: 829-836.
30. Theodoropoulos G, Wise WE, Padmanabhan A, Kerner BA, Taylor CW, Aguilar PS, et al., T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival. Dis Colon Rectum 2002; 45: 895-903.
31. Capirci C, Valentini V, Cionini L, De Paoli A, Rodel C, Glynne-Jones R, et al., Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients. Int J Radiat Oncol Biol Phys 2008; 72: 99-107.
32. Low G, Tho LM, Leen E, Wiebe E, Kakumanu S, McDonald AC, et al., The role of imaging in the pre-operative staging and post-operative follow-up of rectal cancer. Surgeon 2008; 6: 222-231.
33. Shihab OC, Moran BJ, Heald RJ, Quirke P, Brown G,. MRI staging of low rectal cancer. Eur Radiol 2009; 19: 643-650.
34. Kuo LJ, Chern MC, Tsou MH, Liu MC, Jian JJ, Chen CM, et al., Interpretation of magnetic resonance imaging for locally advanced rectal carcinoma after preoperative chemoradiation therapy. Dis Colon Rectum 2005; 48: 23-28.
35. Maretto I, Pomerri F, Pucciarelli S, Mescoli C, Belluco E, Burzi S, et al., The potential of restaging in the prediction of pathologic response after preoperative chemoradiotherapy for rectal cancer. Ann Surg Oncol 2007; 14: 454-461.
36. Suppiah A, Hunter IA, Cowley J, Garimella V, Cast J, Hartley JE, et al., Magnetic resonance imaging accuracy in assessing tumour down-staging following chemoradiation in rectal cancer. Colorectal Dis 2008; 11: 249-253.
37. Koh DM, Chau I, Tait D, Wotherspoon A, Cunningham D, Brown G,. Evaluating mesorectal lymph nodes in rectal cancer before and after neoadjuvant chemoradiation using thin-section T2-weighted magnetic resonance imaging. Int J Radiat Oncol Biol Phys 2008; 71: 456-461.
38. Lahaye MJ, Beets GL, Engelen SM, Kessels AG, de Brune AP, Kwee HW, et al., Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part II. What are the criteria to predict involved lymph nodes? Radiology 2009; 252: 81-91.
39. Koh DM, Brown G, Collins DJ,. Nanoparticles in rectal cancer imaging. Cancer Biomark 2009; 5: 89-98.
40. Lahaye MJ, Engelen SM, Kessels AG, de Brune AP, von Meyenfeldt MF, van Engelshoven JM, et al., USPIO-enhanced MR imaging for nodal staging in patients with primary rectal cancer: predictive criteria. Radiology 2008; 246: 804-811.
41. Read TE, Andujar JE, Caushaj PF, Johnston DR, Dietz DW, Myerson RJ, et al., Neoadjuvant therapy for rectal cancer: histologic response of the primary tumor predicts nodal status. Dis Colon Rectum 2004; 47: 825-831.
42. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Kepka L, Winkler-Spytkowska B, Suwiski R, et al., Prediction of mesorectal nodal metastases after chemoradiation for rectal cancer: results of a randomised trial: implication for subsequent local excision. Radiother Oncol 2005; 76: 234-240.
43. Guillem JG, Díaz-González JA, Minsky BD, Valentini V, Jeong SY, Rodriguez-Bigas MA, et al., cT3 N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted. J Clin Oncol 2008; 26: 368-373.
44. Doll D, Gertler R, Maak M, Friederichs J, Becker K, Geinitz H, et al., Reduced lymph node yield in rectal carcinoma specimen after neoadjuvant radiochemotherapy has no prognostic relevance. World J Surg 2009; 33: 340-347.
45. Chang GJ, Rodriguez-Bigas MA, Eng C, Skibber JM,. Lymph node status after neoadjuvant radiotherapy for rectal cancer is a biologic predictor of outcome. Cancer 2009; 115: 5432-5440.
46. Habr-Gama A, Perez RO, Proscurshim I, Rawet V, Pereira DD, Sousa AH, et al., Absence of lymph nodes in the resected specimen after radical surgery for distal rectal cancer and neoadjuvant chemoradiation therapy: what does it mean? Dis Colon Rectum 2008; 51: 277-283.
47. Dias AR, Nahas CS, Marques CF, Nahas SC, Cecconello I,. Transanal endoscopic microsurgery: indications, results and controversies. Tech Coloproctol 2009; 13: 105-111.
48. Turner J, Saclarides TJ,. Transanal endoscopic microsurgery. Minerva Chir 2008; 63: 401-412.
49. Lezoche E, Guerrieri M, Paganini AM, Feliciotti F,. Long-term results of patients with pT2 rectal cancer treated with radiotherapy and transanal endoscopic microsurgical excision. World J Surg 2002; 26: 1170-1174.
50. Bonnen M, Crane C, Vauthey JN, Skibber J, Delclos ME, Rodriguez-Bigas M, et al., Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients. Int J Radiat Oncol Biol Phys 2004; 60: 1098-1105.
51. Huh JW, Jung EJ, Park YA, Lee KY, Sohn SK,. Preoperative chemoradiation followed by transanal excision for rectal cancer. J Surg Res 2008; 148: 244-250.
52. Mohiuddin M, Marks G, Bannon J,. High-dose preoperative radiation and full thickness local excision: a new option for selected T3 distal rectal cancers. Int J Radiat Oncol Biol Phys 1994; 30: 845-849.
53. Marks G, Mohiuddin MM, Masoni L, Pecchioli L,. High-dose preoperative radiation and full-thickness local excision. A new option for patients with select cancers of the rectum. Dis Colon Rectum 1990; 33: 735-739.
54. Ruo L, Guillem JG, Minsky BD, Quan SH, Paty PB, Cohen AM,. Preoperative radiation with or without chemotherapy and full-thickness transanal excision for selected T2 and T3 distal rectal cancers. Int J Colorectal Dis 2002; 17: 54-58.
55. Nair RM, Siegel EM, Chen DT, Fulp WJ, Yeatman TJ, Malafa MP, et al., Long-term results of transanal excision after neoadjuvant chemoradiation for T2 and T3 adenocarcinomas of the rectum. J Gastrointest Surg 2008; 12: 1797-1805.
56. Caricato M, Borzomati D, Ausania F, Tonini G, Rabitti C, Valeri S, et al., Complementary use of local excision and transanal endoscopic microsurgery for rectal cancer after neoadjuvant chemoradiation. Surg Endosc 2006; 20: 1203-1207.
57. Putter H, Fiocco M, Geskus RB,. Tutorial in biostatistics: competing risks and multi-state models. Stat Med 2007; 26: 2389-2430.
58. Hendren SK, O'Connor BI, Liu M, Asano T, Cohen Z, Swallow CJ, et al., Prevalence of male and female sexual dysfunction is high following surgery for rectal cancer. Ann Surg 2005; 24: 212-223.
59. Heintz A, Mörschel M, Junginger T,. Comparison of results after transanal endoscopic microsurgery and radical resection for T1 carcinoma of the rectum. Surg Endosc 1998; 12: 1145-1148.
60. De Graaf EJ, Doornebosch PG, Tollenaar RA, Meershoek-Klein Kranenbarg E, de Boer AC, Bekkering FC, et al., Transanal endoscopic microsurgery versus total mesorectal excision of T1 rectal adenocarcinomas with curative intention. Eur J Surg Oncol 2009; 35: 1280-1285.
61. Cataldo PA, O'Brien S, Osler T,. Transanal endoscopic microsurgery: a prospective evaluation of functional results. Dis Colon Rectum 2005; 48: 1366-1371.
62. Doornebosch PG, Tollenaar RA, Gosselink MP, Stassen LP, Dijkhuis CM, Schouten WR, et al., Quality of life after transanal endoscopic microsurgery and total mesorectal excision in early rectal cancer. J Colorectal Dis 2007; 9: 553-558.
63. Canda AE, Terzi C, Gorken IB, Oztop I, Sokmen S, Fuzun M,. Effects of preoperative chemoradiotherapy on anal sphincter functions and quality of life in rectal cancer patients. Int J Colorectal Dis 2010; 25: 197-204.
64. Bruheim K, Guren MG, Skovlund E, Hjermstad MJ, Dahl O, Frykholm G, et al., Late side effects and quality of life after radiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 2010; 76: 1005-1011.
65. Francois Y, Nemoz CJ, Baulieux J, Vignal J, Grandjean JP, Partensky C, et al., Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol 1999; 17: 2396.
66. Glynne-Jones R, Wallace M, Livingstone JI, Meyrick-Thomas J,. Complete clinical response after preoperative chemoradiation in rectal cancer: is a 'wait and see' policy justified? Dis Colon Rectum 2008; 51: 10-19.
67. Hiotis SP, Weber SM, Cohen AM, Minsky BD, Paty PB, Guillem JG, et al., Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients. J Am Coll Surg 2002; 194: 131-135.
68. Nakagawa WT, Rossi BM, de O Ferreira F, Ferrigno R, David Filho WJ, Nishimoto IN, et al., Chemoradiation instead of surgery to treat mid and low rectal tumors: is it safe? Ann Surg Oncol 2002; 9: 568-573.
69. Wynn GR, Bhasin N, Macklin CP, George ML,. Complete clinical response to neoadjuvant chemoradiotherapy in patients with rectal cancer: opinions of British and Irish specialists. Colorectal Dis 2009; 12: 327-333.
70. Kuremsky JG, Tepper JE, McLeod HL,. Biomarkers for response to neoadjuvant chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys 2009; 74: 673-688.
71. Smith FM, Gallagher WM, Fox E, Stephens RB, Rexhepaj E, Petricoin EF III, et al., Combination of SELDI-TOF-MS and data mining provides early-stage response prediction for rectal tumors undergoing multimodal neoadjuvant therapy. Ann Surg 2007; 245: 259-266.
72. Smith FM, Reynolds JV, Kay EW, Crotty P, Murphy JO, Hollywood D, et al., COX-2 overexpression in pretreatment biopsies predicts response of rectal cancers to neoadjuvant radiochemotherapy. Int J Radiat Oncol Biol Phys 2006; 64: 466-472.
73. Kandioler D, Zwrtek R, Ludwig C, Janschek E, Ploner M, Hofbauer F, et al., TP53 genotype but not p53 immunohistochemical result predicts response to preoperative short-term radiotherapy in rectal cancer. Ann Surg 2002; 235: 493-498.
74. McDowell DT, Smith FM, Reynolds JV, Maher SG, Adida C, Crotty P, et al., Increased spontaneous apoptosis, but not survivin expression, is associated with histomorphologic response to neoadjuvant chemoradiation in rectal cancer. Int J Colorectal Dis 2009; 24: 1261-1269.
75. Mohiuddin M, Mohiuddin MM, Marks J, Marks G,. Future directions in neoadjuvant therapy of rectal cancer: maximizing pathological complete response rates. Cancer Treat Rev 2009; 35: 547-552.
76. Czito BG, Bendell JC, Willett CG, Morse MA, Blobe GC, Tyler DS, et al., Bevacizumab, oxaliplatin, and capecitabine with radiation therapy in rectal cancer: Phase I trial results. Int J Radiat Oncol Biol Phys 2007; 68: 472-478.
77. Horisberger K, Treschl A, Mai S, Barreto-Miranda M, Kienle P, Ströbel P, et al., Cetuximab in combination with capecitabine, irinotecan, and radiotherapy for patients with locally advanced rectal cancer: results of a Phase II MARGIT trial. Int J Radiat Oncol Biol Phys 2009; 74: 1487-1493.
78. Wiltshire KL, Ward IG, Swallow C, Oza AM, Cummings B, Pond GR, et al., Preoperative radiation with concurrent chemotherapy for resectable rectal cancer: effect of dose escalation on pathologic complete response, local recurrence-free survival, disease-free survival, and overall survival. Int J Radiat Oncol Biol Phys 2006; 64: 709-716.
79. Habr-Gama A, Perez RO, Sabbaga J, Nadalin W, Sao Juliao GP, Gama-Rodrigues J,. Increasing the rates of complete response to neoadjuvant chemoradiotherapy for distal rectal cancer: results of a prospective study using additional chemotherapy during the resting period. Dis Colon Rectum 2009; 52: 1927-1934.
80. Engelen SM, Beets GL, Beets-Tan RG,. Role of preoperative local and distant staging in rectal cancer. Onkologie 2007; 30: 141-145.
81. Zerz A, Müller-Stich BP, Beck J, Linke GR, Tarantino I, Lange J,. Endoscopic posterior mesorectal resection after transanal local excision of T1 carcinomas of the lower third of the rectum. Dis Colon Rectum 2006; 49: 919-924.
82. Zerz A, Beck J, Szinicz G,. [Dorso-posterior extraperitoneal pelviscopy (DEP). From experiment to initial clinical application.] Chirurg 1999; 70: 294-297.
83. Mulsow J, Winter DC, O'Keane JC, O'Connell PR,. Sentinel lymph node mapping in colorectal cancer. Br J Surg 2003; 90: 659-667.
84. Smith FM, Coffey JC, Khasri NM, Walsh MF, Parfrey N, Gaffney E, et al., Sentinel nodes are identifiable in formalin-fixed specimens after surgeon-performed ex vivo sentinel lymph node mapping in colorectal cancer. Ann Surg Oncol 2005; 12: 504-509.
85. Bembenek A, String A, Gretschel S, Schlag PM,. Technique and clinical consequences of sentinel lymph node biopsy in colorectal cancer. Surg Oncol 2008; 17: 183-193.
86. Shah S, Scholz A, Reber H, Schreckenberger M, Viebahn R, Lang H, et al., Laparoscopic radioisotope-guided sentinel lymph node mapping and excision of the rectum - an experimental study. Langenbecks Arch Surg 2009; 394: 483-487.